Tamoxifen therapy for primary breast cancer and risk of contralateral breast cancer.

Li, C I; Malone, K E; Weiss, N S; Daling, J R

Li, C I; Malone, K E; Weiss, N S; Daling, J R.

Affiliation

Li CI; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA. cili@fhcrc.org

J Natl Cancer Inst ; 93(13): 1008-13, 2001 Jul 04.

Article in En | MEDLINE | ID: mdl-11438566

Subject(s)

Breast Neoplasms/drug therapy; Breast Neoplasms/secondary; Neoplasm Recurrence, Local/drug therapy; Neoplasm Recurrence, Local/prevention & control; Tamoxifen/therapeutic use; Age Factors; Aged; Cohort Studies; Female; Humans; Immunohistochemistry; Middle Aged; Models, Statistical; Receptors, Estrogen/biosynthesis; Receptors, Progesterone/biosynthesis; Risk

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Tamoxifen / Breast Neoplasms / Neoplasm Recurrence, Local Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Middle aged Language: En Journal: J Natl Cancer Inst Year: 2001 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links